BPC-157 + TB-500 Blend
Orthogonal Tissue-Repair Blend
Co-lyophilized blend of BPC-157 (angiogenic signalling) and TB-500 (actin-motility). Available in matched 5+5 mg and 10+10 mg ratios.
Blends & Stacks
Category
From $53.99
Price
Research
Grade
Price
From $53.99
✓ 10% off via PeptidesMuscle
Suggested Protocol
Same cadence as the larger blend — 250mcg BPC-157 and 500mcg TB-500 subcutaneously once daily, reconstituted with bacteriostatic water. Use the smaller format for research designs where a single-vial horizon matches the protocol length. Cycling decisions inherit from the underlying individual compounds.
This is the pilot-scale 5mg + 5mg split of the BPC-157/TB-500 co-formulated blend. The research rationale for the combination is identical to the larger vial — BPC-157's angiogenic signalling axis (VEGFR2 upregulation, eNOS-mediated capillary recruitment) paired with TB-500's actin-motility axis (G-actin sequestration, LKKTETQ fragment cell migration). The mechanistic orthogonality is what justifies pre-blending rather than simply dosing more of one compound.
Ingredient Ratio
| Component A | BPC-157 |
|---|---|
| Component B | TB-500 |
Available Sizes
Specifications
| Product | BPC-157 + TB-500 Blend |
|---|---|
| Category | Blends & Stacks |
| Format | Lyophilized powder |
| Price | From $53.99 |
Mechanism Pair Outcomes
Pilot-scale 5mg+5mg split of the full 20mg co-blend
Same orthogonal-mechanism pairing — angiogenesis + actin motility
Sized for 10–12 subQ injections at standard cadence
Fits acute-injury replication windows of ~2 weeks
Reconstituted single-vial horizon before stability concerns
Co-lyophilised with batch COA for both components
Standard Protocol
Same cadence as the larger blend — 250mcg BPC-157 and 500mcg TB-500 subcutaneously once daily, reconstituted with bacteriostatic water. Use the smaller format for research designs where a single-vial horizon matches the protocol length. Cycling decisions inherit from the underlying individual compounds.
Complementary Compounds
Ready to start?
From $53.99
✓ 10% off via PeptidesMuscle
BPC-157 + TB-500 Blend — FAQs
Other Blends & Stacks Peptides
View All
Reta-Cagri 5mg/5mg
The 5mg Retatrutide + 5mg Cagrilintide co-formulated blend — a speculative four-receptor research stack pairing Lilly's GLP-1/GIP/glucagon triple agonist with Novo's long-acting amylin analog, covering amylin + GLP-1 + GIP + glucagon in a single injection.
Cagri-Sema Blend 10mg
The 5mg Cagrilintide + 10mg Semaglutide co-formulated blend — a fixed-ratio research-format version of Novo Nordisk's CagriSema development program (REDEFINE-1 and REDEFINE-2 phase 3 trials), pairing long-acting amylin analog with GLP-1 agonism.
